The U.S. spends $4 billion per year in breast cancer overtreatment costs, according to a new report. The report, published in the journal Health Affairs, found that false-positive mammograms in women cost an estimated $2.8 billion per year in the US between 2012-2013 and the cost of screen-detected invasive cancer …